Market Cap : 115.12 M | Enterprise Value : 81.98 M | PE Ratio : At Loss | PB Ratio : 1.65 |
---|
NAS:STIM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:STIM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Neuronetics has the Growth Rank of 1.
GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:
1. 5-year revenue growth rate, the higher, the better.GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.
Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.
For the Diagnostics & Research subindustry, Neuronetics's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Neuronetics's Growth Rank distribution charts can be found below:
* The bar in red indicates where Neuronetics's Growth Rank falls into.
Thank you for viewing the detailed overview of Neuronetics's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Cannell Capital Llc | 10 percent owner | 245 MERIWETHER CIRCLE ALTA WY 83414 |
Rosengarten Megan | director | C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Cascella Robert | director | C/O HOLOGIC, INC. BEDFORD MA 01730 |
Shook Bruce Joseph | director | 162 CRICKET AVE ARDMORE PA 19003 |
Jaeger Wilfred E | director | C/O THREE ARCH PARTNERS 3200 ALPINE RD PORTOLA VALLEY CA 94028 |
Bakewell John K | director | C/O LANTHEUS MEDICAL IMAGING, INC. 331 TREBLE COVE ROAD NO. BILLERICA MA 01862 |
Conley Sheryl L | director | C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Muir Glenn P | director | C/O HOLOGIC, INC. BEDFORD MA 01730 |
Sullivan Keith J | director, officer: President and CEO | C/O RELIANT TECHNOLOGIES, INC. 464 ELLIS STREET MOUNTAIN VIEW CA 94043 |
Macan William Andrew | officer: Sr. VP, GC, CCO and Secretary | 24275 KATY FREEWAY, SUITE 600 KATY TX 77494 |
Harper Gregory | officer: VP of Prod. Dev. & Operations | C/O NEURONETICS, INC 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Furlong Stephen | officer: CFO | C/O NEURONETICS, INC. 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Tropsha Yelena | officer: VP of Commercial Access | C/O NEURONETICS, INC 3222 PHOENIXVILLE PIKE MALVERN PA 19355 |
Farley Brian E | director | 2200 ZANKER ROAD SUITE F SAN JOSE CA 95131 |
Guthrie Daniel | officer: Chief Commercial Officer | C/O NEURONETICS, INC 322 PHOENIXVILLE PIKE MALVERN PA 19355 |
From GuruFocus
Other Sources
By Zacks 2022-03-09
By Zacks 2021-05-04
By Zacks 2022-02-24
By Seekingalpha 2020-11-03
By Seekingalpha 2021-11-09
By Zacks 2021-03-02
By Zacks 2020-08-04
By Fool 2021-05-04